Luni Emdad
Impact in
- Pathology and Forensic Medicine top 0.5%
- Cancer Mechanisms and Therapy
- Oncology top 1%
- Peptidase Inhibition and Analysis
Papers in
-
- RNA Interference and Gene Delivery 8
- Oncology 46
- CAR-T cell therapy research 13
- Peptidase Inhibition and Analysis 12
- Co-authors
- Paul B. Fisher (113 shared papers)Devanand Sarkar (88 shared papers)Swadesh K. Das (92 shared papers)Praveen Bhoopathi (32 shared papers)Sarmistha Talukdar (22 shared papers)Seok‐Geun Lee (6 shared papers)Xiang‐Yang Wang (17 shared papers)Anjan K. Pradhan (29 shared papers)
- Journals
- Advances in cancer research (26 papers)Cancer Research (13 papers)Oncotarget (9 papers)Proceedings of the National Academy of Sciences (5 papers)Molecular Cancer Therapeutics (5 papers)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Luni Emdad
120 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 115
- Pathology and Forensic Medicine 1.4k
- Oncology 1.7k
- Cancer Research 807
- Molecular Biology 2.8k
- Immunology 770
Countries citing papers authored by Luni Emdad
This map shows the geographic impact of Luni Emdad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luni Emdad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luni Emdad more than expected).
Fields of papers citing papers by Luni Emdad
This network shows the impact of papers produced by Luni Emdad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luni Emdad. The network helps show where Luni Emdad may publish in the future.
Co-authors
The 25 scholars most cited alongside Luni Emdad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 286 | |
| 2 | 2008 | 255 | |
| 3 | 2012 | 218 | |
| 4 | 2008 | 208 | |
| 5 | 2007 | 191 | |
| 6 | 2014 | 189 | |
| 7 | 2014 | 188 | |
| 8 | 2017 | 172 | |
| 9 | 2011 | 160 | |
| 10 | 2019 | 131 | |
| 11 | 2020 | 124 | |
| 12 | 2011 | 109 | |
| 13 | 2014 | 107 | |
| 14 | 2013 | 105 | |
| 15 | 2018 | 98 | |
| 16 | 2010 | 89 | |
| 17 | 2013 | 85 | |
| 18 | 2009 | 83 | |
| 19 | 2012 | 79 | |
| 20 | 2019 | 76 |
About Luni Emdad
Luni Emdad is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Genetics and Cell Biology, having authored 121 papers that have together received 5.5k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (24 papers), Virus-based gene therapy research (21 papers), Hippo pathway signaling and YAP/TAZ (17 papers), Axon Guidance and Neuronal Signaling (15 papers), CAR-T cell therapy research (13 papers), Peptidase Inhibition and Analysis (12 papers), Cancer Research and Treatments (10 papers) and RNA Interference and Gene Delivery (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.4k citations), Oncology (1.7k citations), Cancer Research (807 citations), Molecular Biology (2.8k citations) and Immunology (770 citations). Luni Emdad has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Paul B. Fisher, Devanand Sarkar, Swadesh K. Das, Praveen Bhoopathi, Sarmistha Talukdar, Seok‐Geun Lee, Xiang‐Yang Wang, Anjan K. Pradhan, Mitchell E. Menezes and Xue‐Ning Shen. Their work appears in journals such as Advances in cancer research, Cancer Research, Oncotarget, Proceedings of the National Academy of Sciences and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.